MAPT - COMPREHENSIVE CROSS-DATABASE IDENTIFIER AND FUNCTIONAL MAPPING REFERENCE
Microtubule Associated Protein Tau
Section 1: Gene Identifiers
| Database | Identifier | Notes |
|---|
| HGNC | HGNC:6893 | Approved symbol: MAPT |
| Ensembl | ENSG00000186868 | Human gene |
| NCBI Entrez | 4137 | |
| OMIM | 157140 | Gene/locus entry |
| RefSeq Genomic | NC_000017.11 | |
Full Name: microtubule associated protein tau
Genomic Location:
| Attribute | Value |
|---|
| Chromosome | 17 |
| Cytoband | 17q21.31 |
| Start Position | 45,894,358 |
| End Position | 46,028,334 |
| Strand | + (positive) |
| Gene Length | 133,976 bp |
| Gene Aliases | Locus Type | Gene Groups | Total Transcripts |
|---|
| MTBT1, tau, PPND, FTDP-17, TAU, MSTD, MTBT2, FLJ31424, MGC138549, PPP1R103, tau-40, Tau-PHF6, DDPAC, MAPTL | protein-coding gene | Protein phosphatase 1 regulatory subunits | | |
| | | Transcript Identifiers** | 52 |
Ensembl Transcripts (52 total)
| Transcript ID | Biotype | Start | End | Length |
|---|
| ENST00000262410 | protein_coding | 45,894,554 | 46,028,334 | 133,780 bp |
| ENST00000334239 | protein_coding | 45,894,668 | 46,024,183 | 129,515 bp |
| ENST00000344290 | protein_coding | 45,894,560 | 46,024,425 | 129,865 bp |
| ENST00000351559 | protein_coding | 45,894,554 | 46,028,334 | 133,780 bp |
| ENST00000415613 | protein_coding | 45,962,338 | 46,024,171 | 61,833 bp |
| ENST00000420682 | protein_coding | 45,894,560 | 46,024,659 | 130,099 bp |
| ENST00000431008 | protein_coding | 45,962,338 | 46,024,171 | 61,833 bp |
| ENST00000446361 | protein_coding | 45,894,674 | 46,028,334 | 133,660 bp |
| ENST00000535772 | protein_coding | 45,894,551 | 46,024,225 | 129,674 bp |
| ENST00000570299 | protein_coding_CDS_not_defined | 45,894,576 | 46,018,730 | 124,154 bp |
| ENST00000571311 | nonsense_mediated_decay | 45,894,566 | 45,978,425 | 83,859 bp |
| ENST00000571987 | protein_coding | 45,962,338 | 46,024,171 | 61,833 bp |
| ENST00000572440 | retained_intron | 45,975,492 | 45,980,506 | 5,014 bp |
| ENST00000574436 | protein_coding | 45,962,338 | 46,024,171 | 61,833 bp |
| ENST00000576518 | retained_intron | 45,972,783 | 46,024,431 | 51,648 bp |
| ENST00000577017 | protein_coding_CDS_not_defined | 45,985,659 | 45,987,095 | 1,436 bp |
| ENST00000680542 | nonsense_mediated_decay | 45,894,663 | 46,025,873 | 131,210 bp |
| ENST00000680674 | protein_coding | 45,894,527 | 46,024,655 | 130,128 bp |
| ENST00000703922-ENST00000972120 | various | various | various | - |
Additional 33 protein_coding and alternative transcripts...
RefSeq Transcripts - Human (mRNA)
| Accession | Symbol | Status | MANE Select |
|---|
| NM_001377265 | MAPT | REVIEWED | ✓ MANE Select |
| NM_001123066 | MAPT | REVIEWED | |
| NM_001123067 | MAPT | REVIEWED | |
| NM_001203251 | MAPT | REVIEWED | |
| NM_001203252 | MAPT | REVIEWED | |
| NM_001377266 | MAPT | REVIEWED | |
| NM_001377267 | MAPT | REVIEWED | |
| NM_001377268 | MAPT | REVIEWED | |
| NM_005910 | MAPT | REVIEWED | |
| NM_016834 | MAPT | REVIEWED | |
| NM_016835 | MAPT | REVIEWED | |
| NM_016841 | MAPT | REVIEWED | |
CCDS IDs (10 total)
| CCDS ID |
|---|
| CCDS11499 |
| CCDS11500 |
| CCDS11501 |
| CCDS11502 |
| CCDS45715 |
| CCDS45716 |
| CCDS56033 |
| CCDS92345 |
| CCDS92346 |
| CCDS92347 |
Exons for Representative Transcript (ENST00000344290)
Total Exons: 11
| Exon ID | Start | End | Strand |
|---|
| ENSE00003903194 | 45,894,560 | 45,894,686 | + |
| ENSE00003549966 | 45,962,321 | 45,962,470 | + |
| ENSE00003598892 | 45,971,859 | 45,971,945 | + |
| ENSE00003658894 | 45,978,375 | 45,978,440 | + |
| ENSE00002672395 | 45,982,866 | 45,983,930 | + |
| ENSE00003611335 | 45,987,040 | 45,987,095 | + |
| ENSE00003682122 | 45,991,460 | 45,991,586 | + |
| ENSE00003634058 | 45,996,399 | 45,996,664 | + |
| ENSE00002405491 | 46,014,243 | 46,014,324 | + |
| ENSE00003570976 | 46,018,618 | 46,018,730 | + |
| ENSE00003990316 | 46,023,956 | 46,024,425 | + |
Section 3: Protein Identifiers
UniProt Accessions (5 total)
| Accession | Status | Name |
|---|
| P10636 | ✓ Reviewed (Swiss-Prot) | Microtubule-associated protein tau |
| A0A7I2PJZ2 | Unreviewed | |
| A0A7I2PLE3 | Unreviewed | |
| A0A7P0T936 | Unreviewed | |
| I3L2Z2 | Unreviewed | |
Canonical Protein (P10636):
- Sequence Length: 758 amino acids
- Molecular Mass: 78,928 Da
- Alternative Names: Neurofibrillary tangle protein, Paired helical filament-tau (PHF-tau)
RefSeq Protein Accessions - Human
| Accession | Symbol | Status | MANE Select |
|---|
| NP_001364194 | MAPT | REVIEWED | ✓ MANE Select |
| NP_001116538 | MAPT | REVIEWED | |
| NP_001116539 | MAPT | REVIEWED | |
| NP_001190180 | MAPT | REVIEWED | |
| NP_001190181 | MAPT | REVIEWED | |
| NP_001364195 | MAPT | REVIEWED | |
| NP_001364196 | MAPT | REVIEWED | |
| NP_001364197 | MAPT | REVIEWED | |
Protein Domains and Families
| InterPro ID | Short Name | Type |
|---|
| IPR001084 | MAP_tubulin-bd_rpt | Repeat |
| IPR002955 | Tau | Family |
| IPR027324 | MAP2/MAP4/Tau | Family |
| Pfam |
|---|
| PF00418 (Tau/MAP) | |
| Structure Identifiers** |
Experimental Structures
Total PDB Structures: 274
Top 50 Representative PDB Structures
| PDB ID | Method | Resolution (Å) | Description |
|---|
| 5O3L | Cryo-EM | 3.4 | Paired helical filament in Alzheimer's disease brain |
| 5O3T | Cryo-EM | 3.4 | Straight filament in Alzheimer's disease brain |
| 6GX5 | Cryo-EM | 3.2 | Narrow Pick Filament from Pick's disease brain |
| 6NWP | Cryo-EM | 2.3 | Chronic traumatic encephalopathy Type I Tau filament |
| 6NWQ | Cryo-EM | 3.4 | CTE Type II Tau filament |
| 6TJO | Cryo-EM | 3.2 | TypeI tau filaments - Corticobasal degeneration |
| 6TJX | Cryo-EM | 3.0 | TypeII tau filaments - Corticobasal degeneration |
| 7P65 | Cryo-EM | 2.7 | Progressive supranuclear palsy tau filament |
| 7P66 | Cryo-EM | 3.0 | Globular glial tauopathy type 1 tau filament |
| 7P6A | Cryo-EM | 1.9 | Limbic-predominant neuronal inclusion body 4R tauopathy |
| 7P6D | Cryo-EM | 3.3 | Argyrophilic grain disease type 1 tau filament |
| 8CAQ | Cryo-EM | 2.3 | Tau filaments Type I - Subacute Sclerosing Panencephalitis |
| 8OT6 | Cryo-EM | 2.0 | CTE typeI tau filament from Guam ALS/PDC |
| 8P34 | Cryo-EM | 2.61 | Tau filaments - DeltaK281 mutation |
| 2MZ7 | NMR | - | Structure of Tau(267-312) bound to Microtubules |
| 5N5A | NMR | - | Structure of Tau(254-290) bound to F-actin |
| 2ON9 | X-ray | 1.51 | Amyloid forming peptide VQIVYK |
| 5K7N | MicroED | 1.1 | VQIVYK peptide at high resolution |
| 6ODG | X-ray | 1.0 | SVQIVY tau protein fragment |
| 4FL5 | X-ray | 1.9 | 14-3-3 sigma with Tau pS214 peptide |
| 5E2W | X-ray | 1.5 | Anti-TAU AT8 FAB with triply phosphorylated TAU peptide |
| 6CVJ | Cryo-EM | 3.2 | Synthetic tau bound to microtubule |
| 7PQC | Cryo-EM | 4.1 | tau-microtubule structural ensemble |
| 8FYU | X-ray | 1.85 | CHIP-TPR domain with acetylated tau peptide |
| 1I8H | NMR | - | PIN1 WW domain with phosphothreonine peptide |
Structure Method Summary:
| Method | Count |
|---|
| Cryo-EM (Electron Microscopy) | ~220 |
| X-ray Diffraction | ~45 |
| NMR | ~6 |
| Electron Crystallography | ~3 |
Predicted Structures
AlphaFold Model:
| Attribute | Value |
|---|
| AlphaFold ID | AF-P10636-F1 |
| Sequence Length | 5544 (all isoforms) |
| Global pLDDT | 49.56 |
| Fraction Very High Confidence | 0.00 |
| Note |
|---|
| MAPT is an intrinsically disordered protein, explaining the low AlphaFold confidence scores | |
| Cross-Species Orthologs** |
| Species | Ensembl Gene ID | Symbol | Biotype |
|---|
| Mouse (Mus musculus) | ENSMUSG00000018411 | Mapt | protein_coding |
| Rat (Rattus norvegicus) | ENSRNOG00000005133 | Mapt | protein_coding |
| Zebrafish (Danio rerio) | ENSDARG00000087616 | maptb | protein_coding |
| Zebrafish (Danio rerio) | ENSDARG00000089314 | mapta | protein_coding |
| Additional Entrez orthologs | Note |
|---|
| 440 species | No direct orthologs found in Drosophila melanogaster, C. elegans, or S. cerevisiae (Tau is a vertebrate-specific protein) | |
| | Clinical Variants & AI Predictions** |
ClinVar Variant Summary
Total ClinVar Variants: 601
| Classification | Count |
|---|
| Pathogenic | 28 |
| Likely Pathogenic | 7 |
| Uncertain Significance (VUS) | ~100 |
| Likely Benign | ~200 |
| Benign | ~250 |
| Conflicting | ~16 |
Pathogenic Variants (28 total)
| Variant ID | HGVS Notation | Consequence | Review Status |
|---|
| 14245 | c.2078C>T (p.Pro693Leu) | Missense | Multiple submitters |
| 14247 | c.2392C>T (p.Arg798Trp) | Missense | Multiple submitters |
| 14252 | c.2185G>A (p.Val729Met) | Missense | Multiple submitters |
| 14253 | c.2013T>G (p.Asn671Lys) | Missense | Multiple submitters |
| 14257 | c.2064T>C (p.Asn688=) | Synonymous/splicing | Multiple submitters |
| 14266 | c.1972C>G (p.Leu658Val) | Missense | Multiple submitters |
| 98212 | c.1999-10G>T | Intronic/splice | Multiple submitters |
| 98218 | c.2091+3G>A | Splice donor | Multiple submitters |
| 98222 | c.2091+16C>T | Intronic/splice | Multiple submitters |
| 14246 | c.1991G>T (p.Gly664Val) | Missense | No criteria |
| 14248 | c.2091+14C>T | Splice region | No criteria |
| 14251 | c.2091+1G>A | Splice donor | No criteria |
| 14254 | c.2090G>A (p.Ser697Asn) | Missense | No criteria |
| 14256 | c.2077C>T (p.Pro693Ser) | Missense | No criteria |
| 14258 | c.2201A>T (p.Glu734Val) | Missense | No criteria |
| 14259 | c.1946A>C (p.Lys649Thr) | Missense | No criteria |
| 14260 | c.2282A>T (p.Lys761Ile) | Missense | No criteria |
| 14262 | c.2135C>T (p.Ser712Phe) | Missense | Single submitter |
| 14263 | c.14G>T (p.Arg5Leu) | Missense | No criteria |
| 14267 | c.2231C>T (p.Ser744Leu) | Missense | No criteria |
| 14268 | c.2126A>T (p.Lys709Met) | Missense | No criteria |
| 14269 | c.2084G>T (p.Gly695Val) | Missense | No criteria |
| 2573094 | c.2266C>T (p.Pro756Ser) | Missense | Single submitter |
| 98219 | c.2091+11T>C | Splice region | No criteria |
| 98221 | c.2091+13A>G | Splice region | No criteria |
| 98226 | c.2120T>G (p.Leu707Arg) | Missense | No criteria |
| 98243 | c.2060ATA[1] (p.Asn688del) | In-frame deletion | Single submitter |
| 564448 | 17q21.31 CNV deletion | Copy number loss | No criteria |
Likely Pathogenic Variants (7 total)
| Variant ID | HGVS Notation | Consequence |
|---|
| 2049744 | c.2091+16C>G | Splice region |
| 3075676 | c.2077C>G (p.Pro693Ala) | Missense |
| 3778831 | c.2027T>A (p.Leu676His) | Missense |
| 4056341 | c.2010TAA[1] (p.Asn671del) | In-frame deletion |
| 599620 | c.2260C>T (p.His754Tyr) | Missense |
| 807628 | c.2266C>A (p.Pro756Thr) | Missense |
| 986870 | c.2242T>A (p.Ser748Thr) | Missense |
SpliceAI Predictions
Total Splice-Affecting Variants: 3,502
Top 50 Highest-Scoring Splice Variants
| Variant | Effect | Delta Score |
|---|
| 17:45894684:CAGGT:C | donor_loss | 1.0000 |
| 17:45894685:AGGTA:A | donor_loss | 1.0000 |
| 17:45894686:GGTA:G | donor_loss | 1.0000 |
| 17:45894687:G:GA | donor_loss | 1.0000 |
| 17:45894687:G:GG | donor_gain | 0.9900 |
| 17:45894688:T:A | donor_loss | 0.9900 |
| 17:45894683:TCAG:T | donor_gain | 0.9600 |
| 17:45894685:AG:A | donor_gain | 0.9500 |
| 17:45894686:GG:G | donor_gain | 0.9500 |
| 17:45894682:ATCAG:A | donor_gain | 0.9000 |
| 17:45894684:CAG:C | donor_gain | 0.8900 |
| 17:45896223:G:GT | donor_gain | 0.8100 |
| 17:45896237:G:T | donor_gain | 0.7600 |
| 17:45896223:G:T | donor_gain | 0.7400 |
| 17:45895687:G:GG | donor_gain | 0.7000 |
| 17:45895686:A:AG | donor_gain | 0.6900 |
| 17:45895470:C:T | donor_gain | 0.6700 |
| 17:45894956:G:GA | donor_gain | 0.6400 |
| 17:45894955:TGG:T | donor_gain | 0.6000 |
| 17:45895891:GC:G | donor_gain | 0.5900 |
AlphaMissense Predictions
Total Missense Predictions: 4,906
Distribution by Class
| Class | Approximate Count |
|---|
| Likely Benign | ~4,200 |
| Ambiguous | ~550 |
| Likely Pathogenic | ~156 |
Top 50 Likely Pathogenic Missense Predictions
| Variant | Protein Change | AM Score | Classification |
|---|
| 17:45962359:T:C | F8L | 0.892 | likely_pathogenic |
| 17:45962361:C:A | F8L | 0.892 | likely_pathogenic |
| 17:45962361:C:G | F8L | 0.892 | likely_pathogenic |
| 17:45962350:C:A | R5S | 0.686 | likely_pathogenic |
| 17:45962351:G:C | R5P | 0.569 | likely_pathogenic |
| Note |
|---|
| Most highly pathogenic mutations cluster in the microtubule-binding repeat region (exons 9-13) | |
| Biological Pathways & Gene Ontology** |
Reactome Pathways (3 pathways)
| Pathway ID | Name | Disease Pathway |
|---|
| R-HSA-264870 | Caspase-mediated cleavage of cytoskeletal proteins | No |
| R-HSA-9619483 | Activation of AMPK downstream of NMDARs | No |
| R-HSA-9833482 | PKR-mediated signaling | No |
Gene Ontology Annotations
Total GO Annotations: 100+
Biological Process (Top 20)
| GO ID | Term |
|---|
| GO:0000226 | microtubule cytoskeleton organization |
| GO:0001774 | microglial cell activation |
| GO:0006974 | DNA damage response |
| GO:0007416 | synapse assembly |
| GO:0007611 | learning or memory |
| GO:0007613 | memory |
| GO:0010506 | regulation of autophagy |
| GO:0019896 | axonal transport of mitochondrion |
| GO:0021954 | central nervous system neuron development |
| GO:0031110 | regulation of microtubule polymerization or depolymerization |
| GO:0031116 | positive regulation of microtubule polymerization |
| GO:0031175 | neuron projection development |
| GO:0045773 | positive regulation of axon extension |
| GO:0046785 | microtubule polymerization |
| GO:0048167 | regulation of synaptic plasticity |
| GO:0050808 | synapse organization |
| GO:0051260 | protein homooligomerization |
| GO:0061564 | axon development |
| GO:0097435 | supramolecular fiber organization |
| GO:1990000 | amyloid fibril formation |
Molecular Function (Top 20)
| GO ID | Term |
|---|
| GO:0003677 | DNA binding |
| GO:0003680 | minor groove of adenine-thymine-rich DNA binding |
| GO:0003690 | double-stranded DNA binding |
| GO:0003697 | single-stranded DNA binding |
| GO:0003723 | RNA binding |
| GO:0003779 | actin binding |
| GO:0004857 | enzyme inhibitor activity |
| GO:0008017 | microtubule binding |
| GO:0017124 | SH3 domain binding |
| GO:0019899 | enzyme binding |
| GO:0019901 | protein kinase binding |
| GO:0030674 | protein-macromolecule adaptor activity |
| GO:0034185 | apolipoprotein binding |
| GO:0034452 | dynactin binding |
| GO:0035091 | phosphatidylinositol binding |
| GO:0042802 | identical protein binding |
| GO:0051087 | protein-folding chaperone binding |
| GO:0051721 | protein phosphatase 2A binding |
| GO:0051879 | Hsp90 protein binding |
| GO:0099609 | microtubule lateral binding |
Cellular Component (Top 20)
| GO ID | Term |
|---|
| GO:0005576 | extracellular region |
| GO:0005634 | nucleus |
| GO:0005737 | cytoplasm |
| GO:0005739 | mitochondrion |
| GO:0005829 | cytosol |
| GO:0005874 | microtubule |
| GO:0005886 | plasma membrane |
| GO:0015630 | microtubule cytoskeleton |
| GO:0030424 | axon |
| GO:0030425 | dendrite |
| GO:0030426 | growth cone |
| GO:0030673 | axolemma |
| GO:0043005 | neuron projection |
| GO:0043025 | neuronal cell body |
| GO:0043197 | dendritic spine |
| GO:0044304 | main axon |
| GO:0045121 | membrane raft |
| GO:0045298 | tubulin complex |
| GO:0097418 | neurofibrillary tangle |
| GO:1904115 | axon cytoplasm |
Section 8: Protein Interactions & Molecular Networks
Protein-Protein Interactions
STRING Interactions: 5,558 total
Top 50 Highest-Confidence Interactors
| UniProt ID | Gene | Confidence Score |
|---|
| P10636 | MAPT (self) | 986 |
| P05067 | APP (Amyloid precursor protein) | 986 |
| P21796 | VDAC1 | 974 |
| P02649 | APOE | 973 |
| P37840 | SNCA (Alpha-synuclein) | 971 |
| Q13148 | TARDBP | 970 |
| P06241 | FYN | 958 |
| Q00535 | CDK5 | 948 |
| P49841 | GSK3B | 943 |
| P49768 | PSEN1 | 933 |
| P27348 | YWHAQ (14-3-3 theta) | 903 |
| P35637 | FUS | 889 |
| P23781 | UCHL3 | 886 |
| P49810 | PSEN2 | 883 |
| Q96LT7 | TMEM106B | 852 |
| P04156 | PRNP | 834 |
| P08247 | SNAP25 | 828 |
| P17600 | SYN1 | 826 |
| Q5S007 | LRRK2 | 826 |
| P22303 | ACHE | 811 |
| P04271 | S100B | 802 |
| O60260 | PARK2 (Parkin) | 790 |
| Q8IWL8 | SQSTM1 | 786 |
| Q7Z3B3 | WWOX | 785 |
| P07900 | HSP90AA1 | 772 |
| O43189 | PHF1 | 772 |
| P56817 | BACE1 | 764 |
| P07196 | NEFL | 761 |
| Q9BXM7 | PIAS4 | 751 |
| Q9NUM4 | TRIM13 | 750 |
| P34932 | HSPA4 | 745 |
| P78352 | DLG4 | 735 |
| Q13492 | PICALM | 726 |
| Q9NQ11 | ATG4A | 721 |
| O00499 | BIN1 | 719 |
| P34998 | CRHR1 | 717 |
| Q14114 | LRP8 | 713 |
| P06276 | BCHE | 711 |
| P42858 | HTT (Huntingtin) | 698 |
| P55072 | VCP | 696 |
| P23246 | SFPQ | 694 |
| P12036 | NEFH | 693 |
| P09936 | UCHL1 | 690 |
| P12931 | SRC | 686 |
| P07197 | NEFM | 683 |
| Q13501 | SQSTM1 | 683 |
| P00354 | GAPDH | 680 |
IntAct Interactions
Total IntAct Records: 160+
Key Direct Interactions (high confidence):
| Partner | Type | Score |
|---|
| APP | Direct interaction | 0.75 |
| HSPA8 | Direct interaction | 0.67 |
| MAPT (self) | Direct interaction | 0.67 |
| STUB1 | Physical association | 0.52 |
| FYN | Physical association | 0.59 |
| GSK3B | Physical association | 0.50 |
| AKT1 | Physical association | 0.50 |
| EGFR | Physical association | 0.55 |
Protein Similarity
ESM2 Structural Similarity (76 proteins)
| UniProt ID | Top Similarity | Avg Similarity |
|---|
| Q5YCW0 | 1.0000 | 0.9892 |
| Q5YCW1 | 1.0000 | 0.9891 |
| P10636 (self) | 0.9999 | 0.9890 |
| Q5S6V2 | 0.9999 | 0.9890 |
| Q5YCV9 | 0.9999 | 0.9890 |
| P10637 (MAP2) | 0.9997 | 0.9895 |
| P19332 | 0.9997 | 0.9896 |
| O88778 | 0.9996 | 0.9878 |
| O88737 | 0.9996 | 0.9870 |
| Q3ZB98 | 0.9996 | 0.9833 |
DIAMOND Sequence Homology (19 proteins)
| UniProt ID | Top Identity (%) | Top Bitscore |
|---|
| P10636 (self) | 95.0 | 1070 |
| Q5YCW0 | 99.0 | 1096 |
| Q5YCW1 | 99.0 | 1093 |
| Q5S6V2 | 94.5 | 1072 |
| Q5YCV9 | 93.6 | 1067 |
| P10637 (MAP2) | 90.6 | 966 |
| P19332 | 90.9 | 968 |
| O02828 | 89.8 | 447 |
| P11137 (MAP4) | 79.3 | 2385 |
| P15146 | 89.0 | 2796 |
| P20357 | 89.0 | 2806 |
Section 9: Transcription Factor Regulatory Data
MAPT is NOT a transcription factor
Upstream Regulators (TFs regulating MAPT)
| TF Gene | Regulation | Source |
|---|
| AR | Activates MAPT | CollecTRI |
| DLX3 | Unknown | CollecTRI |
| TFAP2A | Represses MAPT | CollecTRI |
Downstream Targets (Genes regulated BY MAPT)
| Target Gene | Regulation |
|---|
| FOS | Repressed by MAPT |
Note: MAPT's primary function is microtubule stabilization, not transcriptional regulation
SIGNOR Kinase Regulation of MAPT (138 entries)
Key Kinases Phosphorylating MAPT:
| Kinase | Effect | Mechanism | Score |
|---|
| CDK5 | Down-regulates activity | Phosphorylation | 0.76 |
| GSK3B | Down-regulates activity | Phosphorylation | 0.74 |
| CDK5/CDK5R1 | Down-regulates activity | Phosphorylation | 0.70 |
| CAMK2A | Down-regulates activity | Phosphorylation | 0.60 |
| MAPK1 | Down-regulates activity | Phosphorylation | 0.57 |
| FYN | Down-regulates | Phosphorylation | 0.54 |
| LRRK2 | Down-regulates | Phosphorylation | 0.53 |
| MAPK12 | Down-regulates activity | Phosphorylation | 0.53 |
| SYK | Down-regulates | Phosphorylation | 0.47 |
| TTBK1 | Down-regulates | Phosphorylation | 0.45 |
| DYRK1A | Down-regulates | Phosphorylation | 0.43 |
| MARK1 | Down-regulates activity | Phosphorylation | 0.43 |
| PRKACA | Down-regulates activity | Phosphorylation | 0.43 |
| GSK3A | Down-regulates activity | Phosphorylation | 0.43 |
| CSNK1D | Down-regulates | Phosphorylation | 0.37 |
| SGK1 | Down-regulates | Phosphorylation | 0.33 |
| CAPN1 | Down-regulates activity | Cleavage | 0.33 |
| MAPK14 | Up-regulates | Phosphorylation | 0.32 |
| PHKG1 | Down-regulates activity | Phosphorylation | 0.31 |
| CHEK2 | Down-regulates | Phosphorylation | 0.20 |
Phosphatases Dephosphorylating MAPT:
| Phosphatase | Effect | Score |
|---|
| PP2B (Calcineurin) | Up-regulates | 0.20 |
| PPP2R1A (PP2A) | Down-regulates | 0.20 |
Section 10: Drug & Pharmacology Data
ChEMBL Target Information
| ChEMBL Target ID | Name | Type |
|---|
| CHEMBL1293224 | Microtubule-associated protein tau | SINGLE PROTEIN |
| CHEMBL4296122 | KEAP1/Microtubule-associated protein tau | PPI |
| CHEMBL4296123 | KEAP1/Cullin-3/Microtubule-associated protein tau | PPI |
| CHEMBL4296124 | Cullin-3/Microtubule-associated protein tau | PPI |
| CHEMBL6066025 | Protein cereblon/Microtubule-associated protein tau | PPI (PROTAC) |
Total Molecules Targeting MAPT: 95,343+ activity records
Molecules by Development Phase
Phase 4 (Approved) Molecules with Tau Activity: 100+
| ChEMBL ID | Name | Type |
|---|
| CHEMBL1008 | BEPRIDIL | Small molecule |
| CHEMBL101 | PHENYLBUTAZONE | Small molecule |
| CHEMBL103 | PROGESTERONE | Small molecule |
| CHEMBL104 | CLOTRIMAZOLE | Small molecule |
| CHEMBL11 | IMIPRAMINE | Small molecule |
| CHEMBL112 | ACETAMINOPHEN | Small molecule |
| CHEMBL1112 | ARIPIPRAZOLE | Small molecule |
| CHEMBL11359 | CISPLATIN | Small molecule |
| CHEMBL117785 | TETRABENAZINE | Small molecule |
| CHEMBL135 | ESTRADIOL | Small molecule |
| CHEMBL1351 | CARBOPLATIN | Small molecule |
| CHEMBL1083993 | AMIODARONE | Small molecule |
| CHEMBL1200503 | BROMOCRIPTINE | Small molecule |
| CHEMBL1200517 | DIHYDROERGOTAMINE | Small molecule |
| CHEMBL1200561 | DOXAZOSIN | Small molecule |
Phase 3 Molecules:
| ChEMBL ID | Name | Type |
|---|
| CHEMBL10316 | IDAZOXAN | Small molecule |
| CHEMBL109480 | TANESPIMYCIN | Small molecule |
| CHEMBL1130 | DOXIFLURIDINE | Small molecule |
| CHEMBL119443 | ERGONOVINE | Small molecule |
| CHEMBL1255653 | SEPIAPTERIN | Small molecule |
| CHEMBL135400 | ZOPICLONE | Small molecule |
PharmGKB Information
| Attribute | Value |
|---|
| PharmGKB ID | PA238 |
| VIP Gene | Yes |
| CPIC Guideline | No |
VIP = Very Important Pharmacogene
Binding Data
| BindingDB Entries |
|---|
| 675 binding records | |
| Expression Profiles** |
Bgee Expression Summary
| Attribute | Value |
|---|
| Expression Breadth | Ubiquitous |
| Total Present Calls | 141 |
| Max Expression Score | 99.52 |
Top 30 Tissues by Expression Score
| Tissue | Expression Score | Rank |
|---|
| Cortical plate | 99.52 | 226 |
| Superior frontal gyrus | 98.76 | 580 |
| Prefrontal cortex | 98.51 | 694 |
| Frontal cortex | 98.45 | 724 |
| Frontal lobe | 98.45 | 724 |
| Right frontal lobe | 98.32 | 783 |
| Cerebellum | 98.29 | 797 |
| Right hemisphere of cerebellum | 98.29 | 796 |
| Cerebellar cortex | 98.28 | 802 |
| Cerebellar hemisphere | 98.28 | 804 |
| Brodmann area 9 | 98.08 | 898 |
| Primary visual cortex | 98.03 | 921 |
| Dorsolateral prefrontal cortex | 97.88 | 989 |
| Cerebral cortex | 97.87 | 995 |
| Anterior cingulate cortex | 97.39 | 1220 |
| Hypothalamus | 97.34 | 1240 |
| Ammon's horn (Hippocampus) | 97.33 | 1240 |
| Temporal lobe | 97.32 | 1250 |
| Amygdala | 97.29 | 1270 |
| Brain | 96.91 | 1440 |
| Putamen | 96.68 | 1550 |
| Corpus callosum | 96.61 | 1580 |
| Caudate nucleus | 96.58 | 1600 |
| Substantia nigra | 96.45 | 1660 |
| Nucleus accumbens | 96.36 | 1700 |
| Embryo | 95.99 | 1870 |
| Ganglionic eminence | 95.99 | 1870 |
| Gastrocnemius | 95.59 | 2050 |
| Skeletal muscle tissue | 95.52 | 2090 |
| Skeletal muscle organ | 94.64 | 2500 |
Expression pattern: Predominantly neuronal, highest in cortex, cerebellum, and basal ganglia
FANTOM5 Promoter Data
Total Promoters: 10
| Promoter ID | TPM Average | Samples Expressed |
|---|
| 161306 | 23.34 | 717 |
| 161305 | 5.18 | 597 |
| 161307 | 3.08 | 334 |
| 161309 | 1.63 | 147 |
| 161308 | 0.36 | 101 |
| 161304 | 0.27 | 77 |
| 161311 | 0.21 | 90 |
| 161317 | 0.06 | 31 |
| 161320 | 0.04 | 21 |
| 161310 | 0.03 | 11 |
Single-Cell Expression Data (6 datasets)
| Experiment ID | Description | Cells |
|---|
| E-MTAB-8894 | Human fetal lateral ganglionic eminence | 150,129 |
| E-MTAB-9154 | iPSC derived neurons under genetic/toxic stressors | 36,117 |
| E-HCAD-5 | Organoids modeling inter-individual variation | 25,049 |
| E-MTAB-10485 | Neural progenitors during brain development | 18,649 |
| E-GEOD-93593 | 125-day H1 hESC differentiation to ventral cell types | 1,733 |
| E-GEOD-75140 | Cerebral organoids recapitulating fetal neocortex | 734 |
Section 12: Disease Associations
Mendelian/Monogenic Disease Links (GenCC)
| Disease | Classification | Inheritance | Submitter |
|---|
| Pick disease | Strong | Autosomal dominant | Genomics England, Invitae |
| Supranuclear palsy, progressive, 1 | Strong | Autosomal dominant | Genomics England |
| Semantic dementia | Strong | Autosomal dominant | Genomics England |
| Late-onset Parkinson disease | Strong/Limited | Autosomal dominant | Genomics England |
| Progressive supranuclear palsy-parkinsonism | Moderate/Limited | Autosomal recessive | Genomics England |
Orphanet Disease Associations (8 diseases)
| Orphanet ID | Disease Name | Type | Phenotypes |
|---|
| 275864 | Behavioral variant of frontotemporal dementia | Disease | 40 |
| 100070 | Progressive non-fluent aphasia | Disease | 32 |
| 240071 | Classic progressive supranuclear palsy syndrome | Clinical subtype | 28 |
| 240103 | PSP-corticobasal syndrome | Clinical subtype | 30 |
| 240094 | PSP-pure akinesia with gait freezing | Clinical subtype | 21 |
| 240112 | PSP-progressive non-fluent aphasia syndrome | Clinical subtype | 21 |
| 240085 | PSP-predominant parkinsonism syndrome | Clinical subtype | 20 |
| 100069 | Semantic dementia | Disease | 10 |
HPO Phenotype Associations (160 phenotypes)
Top 50 Phenotypes
| HPO ID | Phenotype |
|---|
| HP:0000006 | Autosomal dominant inheritance |
| HP:0000726 | Dementia |
| HP:0002145 | Frontotemporal dementia |
| HP:0001300 | Parkinsonism |
| HP:0002185 | Neurofibrillary tangles |
| HP:0000738 | Hallucinations |
| HP:0000716 | Depression |
| HP:0000741 | Apathy |
| HP:0001260 | Dysarthria |
| HP:0001288 | Gait disturbance |
| HP:0002063 | Rigidity |
| HP:0002067 | Bradykinesia |
| HP:0002172 | Postural instability |
| HP:0002381 | Aphasia |
| HP:0002354 | Memory impairment |
| HP:0002059 | Cerebral atrophy |
| HP:0001332 | Dystonia |
| HP:0001337 | Tremor |
| HP:0002015 | Dysphagia |
| HP:0000511 | Vertical supranuclear gaze palsy |
| HP:0000605 | Supranuclear gaze palsy |
| HP:0000514 | Slow saccadic eye movements |
| HP:0002300 | Mutism |
| HP:0002186 | Apraxia |
| HP:0000751 | Personality changes |
| HP:0000734 | Disinhibition |
| HP:0000719 | Inappropriate behavior |
| HP:0002359 | Frequent falls |
| HP:0002317 | Unsteady gait |
| HP:0002304 | Akinesia |
| HP:0007354 | Amyotrophic lateral sclerosis |
| HP:0002446 | Astrocytosis |
| HP:0002171 | Gliosis |
| HP:0002529 | Neuronal loss in central nervous system |
| HP:0003581 | Adult onset |
| HP:0003584 | Late onset |
| HP:0003596 | Middle age onset |
| HP:0003676 | Progressive |
| HP:0006892 | Frontotemporal cerebral atrophy |
| HP:0007112 | Temporal cortical atrophy |
| HP:0012444 | Brain atrophy |
| HP:0100256 | Senile plaques |
| HP:0100315 | Lewy bodies |
| HP:0011098 | Speech apraxia |
| HP:0002439 | Frontolimbic dementia |
| HP:0002427 | Expressive aphasia |
| HP:0002463 | Language impairment |
| HP:0002380 | Fasciculations |
| HP:0031825 | Freezing of gait |
| HP:0002322 | Resting tremor |
GWAS Associations (124 associations)
Top 30 GWAS Traits
| Study ID | Trait | P-value | Mapped Gene |
|---|
| GCST001116_8 | Progressive supranuclear palsy | 2×10⁻¹¹⁸ | MAPT |
| GCST004902_11 | Parkinson's disease | 1×10⁻⁶⁸ | MAPT |
| GCST001445_4 | Parkinson's disease | 8×10⁻⁵² | - |
| GCST002544_5 | Parkinson's disease | 2×10⁻⁴⁸ | MAPT |
| GCST005116_49 | Male-pattern baldness | 1×10⁻²⁶ | MAPT |
| GCST005232_115 | Neuroticism | 8×10⁻²⁶ | LINC02210-CRHR1 |
| GCST007328_48 | Alcohol consumption | 8×10⁻²⁵ | MAPT-AS1 |
| GCST008757_26 | Alcohol consumption | 5×10⁻²³ | MAPT |
| GCST006418_5 | Progressive supranuclear palsy | 4×10⁻¹¹³ | - |
| GCST007845_1 | Progressive supranuclear palsy | 2×10⁻²² | MAPT |
| GCST001116_6 | Progressive supranuclear palsy | 9×10⁻¹⁸ | MAPT |
| GCST000959_11 | Parkinson's disease | 1×10⁻²⁸ | LINC02210 |
| GCST000528_6 | Parkinson's disease | 2×10⁻¹⁶ | LINC02210-CRHR1 |
| GCST010083_316 | Hemoglobin levels | 1×10⁻⁶¹ | MAPT |
| GCST090002403_409 | Red blood cell count | 9×10⁻⁶⁶ | MAPT |
| GCST010703_137 | Brain morphology | 2×10⁻⁶⁵ | KANSL1 |
| GCST001483_2 | Intracranial volume | 8×10⁻¹⁵ | KANSL1 |
| GCST005337_8 | Headache | 6×10⁻¹⁵ | LINC02210-CRHR1 |
| GCST006268_366 | Reaction time | 6×10⁻¹⁵ | MAPT |
| GCST001968_12 | Interstitial lung disease | 9×10⁻¹⁴ | MAPT |
| GCST003872_11 | QRS complex | 2×10⁻¹⁴ | MAPT |
| GCST006269_6 | General cognitive ability | 1×10⁻¹³ | MAPT |
| GCST007938_6 | Medication use (anilides) | 8×10⁻¹³ | MAPT |
| GCST002971_2 | Corticobasal degeneration | 1×10⁻¹² | LINC02210 |
| GCST004092_1 | Plasma t-tau levels | 1×10⁻¹² | MAPT |
| GCST006269_191 | General cognitive ability | 1×10⁻¹¹ | MAPT |
| GCST001482_17 | Lumbar spine bone mineral density | 5×10⁻¹¹ | MAPT |
| GCST012228_609 | Waist-hip index | 6×10⁻¹¹ | MAPT |
| GCST000855_1 | Parkinson's disease | 7×10⁻¹² | MAPT |
| GCST010427_22 | Left-right brain asymmetry | 1×10⁻²⁰ | MAPT |
SUMMARY STATISTICS
| Category | Count |
|---|
| Total Transcripts | 52 |
| RefSeq mRNA (Human) | 12 |
| CCDS IDs | 10 |
| UniProt Entries | 5 (1 reviewed) |
| PDB Structures | 274 |
| InterPro Domains | 3 |
| ClinVar Variants | 601 |
| Pathogenic Variants | 28 |
| Likely Pathogenic | 7 |
| SpliceAI Predictions | 3,502 |
| AlphaMissense Predictions | 4,906 |
| GO Annotations | 100+ |
| Reactome Pathways | 3 |
| STRING Interactions | 5,558 |
| IntAct Records | 160+ |
| SIGNOR Regulations | 138 |
| HPO Phenotypes | 160 |
| GWAS Associations | 124 |
| Orphanet Diseases | 8 |
| ChEMBL Activities | 95,343+ |
| FANTOM5 Promoters | 10 |
| Single-Cell Datasets | 6 |
| Orthologs | 4 (vertebrates only) |
DATA SOURCES
HGNC - HUGO Gene Nomenclature Committee
Ensembl - Genome browser (release 113)
NCBI Entrez Gene - Gene database
OMIM - Online Mendelian Inheritance in Man
UniProt - Protein sequence and function
RefSeq - Reference sequences
CCDS - Consensus Coding Sequence
PDB - Protein Data Bank
AlphaFold - Protein structure predictions
ClinVar - Clinical variant interpretations
SpliceAI - Splice variant predictions
AlphaMissense - Missense pathogenicity predictions
Gene Ontology - Functional annotations
Reactome - Biological pathways
STRING - Protein-protein interactions
IntAct - Molecular interactions
SIGNOR - Signaling network
CollecTRI - Transcription factor interactions
ChEMBL - Drug and bioactivity data
PharmGKB - Pharmacogenomics
Bgee - Gene expression
FANTOM5 - Transcription start sites
HPO - Human Phenotype Ontology
GenCC - Gene-disease validity
Orphanet - Rare diseases
GWAS Catalog - Genome-wide association studies
Reference compiled from Biobtree integrated biological databases
Date: 2026-03-27
I have compiled a comprehensive cross-database identifier and functional mapping reference for human MAPT (Microtubule Associated Protein Tau).
Key highlights:
Gene Location: Chromosome 17q21.31 (45,894,358-46,028,334, + strand)
Identifiers: HGNC:6893, ENSG00000186868, Entrez 4137, OMIM 157140
Transcripts: 52 Ensembl transcripts, 12 human RefSeq mRNAs, MANE Select: NM_001377265
Protein: P10636 (758 aa, 79 kDa), intrinsically disordered
Structures: 274 PDB entries (predominantly Cryo-EM of disease-associated fibrils)
Clinical Variants: 601 ClinVar entries (28 pathogenic, 7 likely pathogenic)
AI Predictions: 3,502 SpliceAI variants, 4,906 AlphaMissense predictions
Interactions: 5,558 STRING interactors, key partners include APP, GSK3B, CDK5, APOE
Drug Data: 95,343+ ChEMBL activity records, designated VIP gene in PharmGKB
Expression: Highest in brain (cortex, cerebellum, hippocampus, substantia nigra)
Diseases: Frontotemporal dementia, Pick disease, PSP, Parkinson’s disease, Alzheimer’s disease (via neurofibrillary tangles)
GWAS: 124 associations including PSP (p=2×10⁻¹¹⁸), Parkinson’s (p=1×10⁻⁶⁸)